好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Patient Perception Confounds True Recovery After Stroke
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (5:30 PM-6:30 PM)
3-043
In this study, we examine the relationship between patient- versus clinician-reported recovery metrics and quality of life (QOL) after stroke.
 QOL is important when considering a patient’s recovery after stroke. It is often assumed that clinician-reported factors such as stroke severity and functional status, typically measured by scales including the Barthel Index (BI) and NIH Stroke Scale (NIHSS), are predictors of QOL. However, less is known regarding a patients’ own ability to accurately assess their recovery, or if their assessment, evaluated using patient-reported metrics, is more directly tied to their QOL.

Patients were seen in clinic 1 and 6 months post-stroke. Assessment tools included the NIHSS, BI, modified Rankin Scale (mRS), Montreal Cognitive Assessment (MoCA), and Likert scales assessing patient-reported outcomes: percent recovered and satisfaction with recovery (QOL). Demographic information was also collected. Regression analyses were used to determine factors associated with QOL after stroke.

Data were collected for 42 patients returning 1 month post-stroke, and 24 patients returning at 6 months. At both time points, QOL was strongly associated with a patient’s report of their percent recovery (p=0.006 and <0.001 respectively), but not with NIHSS, mRS, BI, or MoCA scores.

While true functional recovery is ideal following stroke, patient perception is also important. Our results suggest that the two are independent and that QOL is more closely related to patient-reported outcomes than to commonly used functional assessments. Clinician-reported outcomes may not accurately reflect QOL. Patients’ perception of recovery should be an integral part of assessing post-stroke recovery.
Authors/Disclosures
Elisabeth B. Marsh, MD, FAAN (Johns Hopkins School of Medicine)
PRESENTER 		Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Neurological Association. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN. The institution of Dr. Marsh has received research support from American Heart Association. The institution of Dr. Marsh has received research support from National Institutes of Health. The institution of Dr. Marsh has received research support from National Institutes of Health.
No disclosure on file
Sheena Khan No disclosure on file
No disclosure on file